2[2]Rosen G, Huvos AG, Mosende C,et al. Chemotherapy and thoractomy for metastatic osteogenic sarcoma: a model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery[J ]. Cancer, 1978,41(2) :841.
3[3]Dicke KA. Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies [J ]. Transplantation, 1986,41 ( 1 ): 4.
4[4]Gale RP . Autologous bone marrow teansplatation in patients with cancer[J]. Exp Hematol 1979,7(4) :351.
5[5]Cheson BD . Autologous bone marrow transplantation: Current status and future direcyions [J ]. Ann Intern Med, 1989, 110 ( 1 ):51.
6[6]Rosen G, Nirenberg A, Chemotherapy for osteogenic sarcoma:an investigative method,not a recipe [J ]. Cancer Treat Rep, 1982,66(9) :1687.
7[7]Goorin AM, Perez - Atayde A, Gebhardt M, et al. Weekly highdose methotrexate and doxorubicin for osteosarcoma: the DanaFather cancer institute the children's hospital study Ⅲ [J]. J Clin Oncol, 1987,5(8): 1178.
8[8]Gribben JG. Double ABMT in acute myeloid leukemia [J ]. Bone Marrow Transplantalon 1989,4 (suppl): 209.
同被引文献7
1Reed E,Kessinger A,Murphy B,et al.Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4-9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation[J].Bone Marrow Transplant,2003,31(7):571.
2Schrama JG,Baars JW,Holtkamp MJ,et al.Phase Ⅱ study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide,thiotepa,and carboplatin in stage Ⅳ breast cancer[J].Bone Marrow Transplant,2001,28(2):173.
3Elias AD,Richardson P,Avigan D.et al.A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer[J].Bone Marrow Transplant,2001,27(3):269.
4Berry DA,Broadwater G,Klein JP.et al.High-dose versus standard chemotherapy in metastatic breast cancer:comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry[J].J Clin Oncol,2002,20(3):743.
5Bengala C,Pazzagli I,Innocenti F.et al.High-dose thiot-epa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel- containing regimens in metastatic breast cancer(MBC)[J].Ann Oncol,2001,12(1):69.
6Stuart MJ,Peters WP,Broadwater G.et al.High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes[J].Biol Blood Marrow Transplant,2002,8(12):666.
7Tartarone A,Sirotova Z,Aieta M.et al.Salvage treatment with epirubicin and/or paclitaxel in metastatic breast cancer patients relapsed after high-dose chemotherapy with peripheral blood progenitor cells[J].Tumori,2001,87(3):134.
